Subscribe free

HPB & Spleen ·

Pathological response correlates with improved survival in UHCC patients

In a study of 76 patients with unresectable hepatocellular carcinoma (UHCC) undergoing conversion surgery after triple therapy, major pathological response (MPR) and pathological complete response (PCR) were observed in 69.7% and 32.9% of cases, respectively. Those achieving MPR had significantly higher overall survival rates at one and two years compared to non-MPR patients (100.0% and 91.3% versus 67.7% and 19.4%). Pathological response may serve as a valuable prognostic marker.

Journal Article by Zeng ZX, Wu JY (…) Yan ML et 10 al. in Liver Cancer

© 2024 The Author(s). Published by S. Karger AG, Basel.
© 2024 The Author(s). Published by S. Karger AG, Basel.

read the whole article in Liver Cancer

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →